| Regulatory role of G protein–coupled estrogen receptor for vascular function and obesity E Haas, I Bhattacharya, E Brailoiu, M Damjanović, GC Brailoiu, X Gao, ... Circulation research 104 (3), 288-291, 2009 | 436 | 2009 |
| Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors MR Meyer, DJ Clegg, ER Prossnitz, M Barton Acta Physiologica 203 (1), 259-269, 2011 | 367 | 2011 |
| Postmenopausal hypertension: mechanisms and therapy M Barton, MR Meyer Hypertension 54 (1), 11-18, 2009 | 355 | 2009 |
| Differential effects of 17β-estradiol on function and expression of estrogen receptor α, estrogen receptor β, and GPR30 in arteries and veins of patients with atherosclerosis E Haas, MR Meyer, U Schurr, I Bhattacharya, R Minotti, HH Nguyen, ... Hypertension 49 (6), 1358-1363, 2007 | 214 | 2007 |
| Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling MR Meyer, E Haas, M Barton Hypertension 47 (6), 1019-1026, 2006 | 203 | 2006 |
| Obesity and risk of vascular disease: importance of endothelium‐dependent vasoconstriction M Barton, O Baretella, MR Meyer British journal of pharmacology 165 (3), 591-602, 2012 | 195 | 2012 |
| G protein-coupled estrogen receptor protects from atherosclerosis MR Meyer, NC Fredette, TA Howard, C Hu, C Ramesh, C Daniel, ... Scientific reports 4 (1), 7564, 2014 | 190 | 2014 |
| The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function MR Meyer, ER Prossnitz, M Barton Vascular pharmacology 55 (1-3), 17-25, 2011 | 189 | 2011 |
| Non-genomic regulation of vascular cell function and growth by estrogen MR Meyer, E Haas, ER Prossnitz, M Barton Molecular and cellular endocrinology 308 (1-2), 9-16, 2009 | 161 | 2009 |
| Role of GPER in estrogen-dependent nitric oxide formation and vasodilation NC Fredette, MR Meyer, ER Prossnitz The Journal of steroid biochemistry and molecular biology 176, 65-72, 2018 | 145 | 2018 |
| Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780 MR Meyer, O Baretella, ER Prossnitz, M Barton Pharmacology 86 (1), 58-64, 2010 | 141 | 2010 |
| Estrogens and coronary artery disease: new clinical perspectives MR Meyer, M Barton Advances in Pharmacology 77, 307-360, 2016 | 91 | 2016 |
| Regulation of vascular smooth muscle tone by adipose-derived contracting factor MR Meyer, NC Fredette, M Barton, ER Prossnitz PloS one 8 (11), e79245, 2013 | 91 | 2013 |
| Deletion of G Protein–Coupled estrogen receptor increases endothelial vasoconstriction MR Meyer, K Amann, AS Field, C Hu, HJ Hathaway, NL Kanagy, ... Hypertension 59 (2), 507-512, 2012 | 85 | 2012 |
| Post-myocardial infarction (MI) care: medication adherence for secondary prevention after MI in a large real-world population CA Huber, MR Meyer, J Steffel, E Blozik, O Reich, T Rosemann Clinical therapeutics 41 (1), 107-117, 2019 | 80 | 2019 |
| GPER regulates endothelin-dependent vascular tone and intracellular calcium MR Meyer, AS Field, NL Kanagy, M Barton, ER Prossnitz Life sciences 91 (13-14), 623-627, 2012 | 79 | 2012 |
| ERα, ERβ, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis MR Meyer, M Barton Cardiovascular research 83 (4), 605-610, 2009 | 78 | 2009 |
| Obligatory role for GPER in cardiovascular aging and disease MR Meyer, NC Fredette, C Daniel, G Sharma, K Amann, JB Arterburn, ... Science signaling 9 (452), ra105-ra105, 2016 | 77 | 2016 |
| Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? M Barton, MR Meyer, E Haas Arteriosclerosis, Thrombosis, and Vascular Biology 27 (8), 1669-1672, 2007 | 71 | 2007 |
| Accelerated vascular aging as a paradigm for hypertensive vascular disease: prevention and therapy M Barton, M Husmann, MR Meyer Canadian Journal of Cardiology 32 (5), 680-686. e4, 2016 | 65 | 2016 |
Matthias Barton, MDProfessor of Cardiology, University of ZurichVerified email at access.uzh.ch